The Chinese Ebola vaccine has three major features- the vaccine is the first based on the Ebola virus strain responsible for the West African outbreak in 2014.

Second, the Chinese vaccine is currently in the form of a freeze-dried powder which will keep it stable for at least two weeks in temperatures of up to 37 degrees Celsius. This will also make it suitable for the tropical West African region and assist with large-scale production.
Thirdly, clinical outcomes have proved the safety and efficacy of the Ebola vaccine. Phase one of clinical trials of the Chinese Ebola vaccine that included human testing indicates that the vaccine is safe.
Source-IANS
MEDINDIA



Email










